NCT00570830View on ClinicalTrials.gov

Retisert and Cataract Surgery in Patients With Severe Uveitis

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

May 31, 2008

Conditions
Intermediate UveitisPosterior Uveitis
Interventions
DEVICE

Retisert (fluocinolone acetonide implant)

Patients with intermediate, posterior or pan-uveitis underwent simultaneous fluocinolone acetonide implantation (0.59 mg or 2.1 mg) and phacoemulsification and intraocular lens.

Trial Locations (1)

07710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER